fibrinogen has been researched along with Leukemia, Myelomonocytic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aul, C; Bauser, U; Boogen, C; Frieling, T; Germing, U; Heyll, A; Kobbe, G; Schneider, P; Söhngen, D | 1 |
| Scharf, RE; Schneider, W; Stoffels, U | 1 |
2 other study(ies) available for fibrinogen and Leukemia, Myelomonocytic, Acute
| Article | Year |
|---|---|
Double treatment of severe hepatic veno-occlusive disease after allogeneic peripheral blood progenitor cell transplantation with recombinant tissue plasminogen activator.
Topics: Acute Kidney Injury; Female; Fibrinogen; Fibrinolytic Agents; Hematopoietic Stem Cell Transplantation; Heparin; Hepatic Veno-Occlusive Disease; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Recombinant Proteins; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator; Transplantation Conditioning; Transplantation, Homologous | 1997 |
Thrombin generation in acute myeloblastic leukemia.
Topics: Fibrinogen; Fibrinopeptide A; Hemorrhagic Disorders; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukocyte Count; Neoplastic Stem Cells; Thrombin | 1990 |